PNC Financial Services Group Inc. Has $810,000 Stock Holdings in Neogen Co. (NASDAQ:NEOG)

PNC Financial Services Group Inc. lessened its holdings in shares of Neogen Co. (NASDAQ:NEOGFree Report) by 5.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 40,260 shares of the company’s stock after selling 2,405 shares during the period. PNC Financial Services Group Inc.’s holdings in Neogen were worth $810,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of NEOG. Allspring Global Investments Holdings LLC grew its holdings in Neogen by 416.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,033 shares of the company’s stock worth $56,000 after acquiring an additional 2,446 shares during the period. C M Bidwell & Associates Ltd. acquired a new stake in Neogen during the 3rd quarter worth $151,000. Savant Capital LLC grew its holdings in Neogen by 9.4% during the 3rd quarter. Savant Capital LLC now owns 10,320 shares of the company’s stock worth $191,000 after acquiring an additional 889 shares during the period. Fox Run Management L.L.C. acquired a new stake in Neogen during the 3rd quarter worth $201,000. Finally, Vise Technologies Inc. acquired a new stake in Neogen during the 4th quarter worth $220,000. Institutional investors and hedge funds own 96.73% of the company’s stock.

Neogen Price Performance

Shares of NEOG stock opened at $13.19 on Friday. Neogen Co. has a 12-month low of $11.46 and a 12-month high of $24.09. The firm has a market capitalization of $2.86 billion, a price-to-earnings ratio of 1,319.00 and a beta of 1.18. The company has a quick ratio of 2.66, a current ratio of 3.82 and a debt-to-equity ratio of 0.28. The firm has a fifty day moving average of $13.19 and a 200-day moving average of $15.93.

Neogen (NASDAQ:NEOGGet Free Report) last announced its quarterly earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). Neogen had a net margin of 0.17% and a return on equity of 3.35%. The firm had revenue of $228.80 million during the quarter, compared to analyst estimates of $230.01 million. During the same period last year, the firm earned $0.12 EPS. Neogen’s quarterly revenue was up 4.8% on a year-over-year basis. On average, equities research analysts forecast that Neogen Co. will post 0.46 earnings per share for the current year.

Insider Activity at Neogen

In related news, CEO John Edward Adent acquired 23,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 10th. The shares were acquired at an average cost of $12.36 per share, with a total value of $284,280.00. Following the transaction, the chief executive officer now owns 152,389 shares of the company’s stock, valued at approximately $1,883,528.04. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, COO Douglas Edward Jones acquired 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 17th. The shares were acquired at an average cost of $12.36 per share, with a total value of $123,600.00. Following the transaction, the chief operating officer now owns 46,131 shares of the company’s stock, valued at approximately $570,179.16. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John Edward Adent acquired 23,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 10th. The stock was bought at an average cost of $12.36 per share, for a total transaction of $284,280.00. Following the completion of the transaction, the chief executive officer now directly owns 152,389 shares in the company, valued at approximately $1,883,528.04. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 53,000 shares of company stock valued at $662,205. 0.71% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Separately, Piper Sandler lowered their target price on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, April 15th.

Check Out Our Latest Report on NEOG

Neogen Profile

(Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

Featured Articles

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.